Pittman Scott M. — SEC Form 4 filings

SEC reporting owner CIK 1674752. 8 Form 4 filings on record with FilingPulse; latest filed 2026-07-02.

Transaction summary — filings shown

Covers all 8 filings on record, filed 2024-05-21 to 2026-07-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Nuo Therapeutics, Inc. (AURX)Director, 10% owner827

Form 4 filings — Pittman Scott M.

FiledFormIssuerReported transactionsSource
2026-07-024Nuo Therapeutics, Inc. (AURX)Option exercise (M): 40,000 @ $1 · Tax withholding (F): 39,604 @ $1.01 · Option exercise (M): 40,000 (derivative) @ $0 · Grant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-024/ANuo Therapeutics, Inc. (AURX)Grant/award (A): 30,050 (derivative) @ $1.50 · Grant/award (A): 36,750 (derivative) @ $1.50 · Grant/award (A): 7,516 (derivative) @ $1.50EDGAR
2026-06-024Nuo Therapeutics, Inc. (AURX)Grant/award (A): 17,450 (derivative) @ $1.50 · Disposition to issuer (D): 36,750 (derivative) @ $1.50 · Disposition to issuer (D): 7,516 (derivative) @ $1.50 · Grant/award (A): 17,500 (derivative) @ $1.50 · Grant/award (A): 7,333 (derivative) @ $1.50EDGAR
2026-01-264Nuo Therapeutics, Inc. (AURX)Grant/award (A): 2,050 (derivative) @ $1.50 · Grant/award (A): 1,333 (derivative) @ $1.50 · Grant/award (A): 26,667 (derivative) @ $1.50 · Grant/award (A): 1,750 (derivative) @ $1.50 · Grant/award (A): 35,000 (derivative) @ $1.50 · Grant/award (A): 7,516 (derivative) @ $1.50EDGAR
2025-08-014Nuo Therapeutics, Inc. (AURX)Grant/award (A): 3,946 @ $1.50EDGAR
2024-11-194Nuo Therapeutics, Inc. (AURX)Option exercise (M): 121,875 @ $0.40 · Option exercise (M): 62,500 @ $0.40 · Option exercise (M): 33,334 @ $0.50 · Option exercise (M): 121,875 (derivative) @ $0 · Option exercise (M): 62,500 (derivative) @ $0 · Option exercise (M): 33,334 (derivative) @ $0EDGAR
2024-07-224Nuo Therapeutics, Inc. (AURX)Grant/award (A): 40,000 (derivative) @ $0.33EDGAR
2024-05-214Nuo Therapeutics, Inc. (AURX)Grant/award (A): 135,000 @ $0.75EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1674752 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →